Adaptive Phase I & II Trials

Rapid approval, flexible conduct, adaptive protocols in a MHRA accredited facility.

View service

Phase III Clinical Studies

Fast and efficient patient recruitment for Phase III clinical trials.

View service

TQT Studies

Cardiac safety assessments are built into every clinical study.

View service

Bridging Studies

Fast track your global marketing authorisations with our ethnic bridging studies.

View service

Patient Recruitment

Fast and efficient in-house team, specialising in patient recruitment.

View service

Data Management

Flexible, efficient and tailored to our clients’ needs.

View service

Latest news

Richmond CEO Presents Landmark Data on Repeat-Dose Gene Editing

September 9, 2024
Richmond CEO Presents Landmark Data on Repeat-Dose Gene Editing
Read more

Richmond promotes new Director of Communications and Participant Engagement

August 12, 2024
Richmond Pharmacology is delighted to announce the promotion of Liz Romano to the new position of Director of Communications and Participant Engagement.
Read more

Events

Pulse Virtual: Respiratory, CVD, Diabetes and Nutrition

Wednesday 18th September
Richmond will be presenting at the upcoming Pulse Virtual Event aimed at GPs
View event